Common Stock, Shares, Outstanding of TG THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
TG THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • TG THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 155,305,953, a 0.34% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

TG THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 155,305,953 -530,303 -0.34% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 155,210,533 -566,758 -0.36% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 158,025,237 +3,192,699 +2.1% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 158,168,688 +3,602,945 +2.3% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 155,836,256 +4,411,967 +2.9% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 155,777,291 +4,327,869 +2.9% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 154,832,538 +3,904,524 +2.6% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 154,565,743 +5,169,705 +3.5% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 151,424,289 +5,038,901 +3.4% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 151,449,422 +6,091,587 +4.2% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 150,928,014 +5,771,265 +4% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 149,396,038 +4,854,013 +3.4% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 146,385,388 +3,134,654 +2.2% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 145,357,835 +2,414,696 +1.7% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 145,156,749 +2,324,263 +1.6% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 144,542,025 +3,062,638 +2.2% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 143,250,734 +2,674,437 +1.9% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 142,943,139 +14,024,587 +11% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 142,832,486 +16,183,281 +13% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 141,479,387 +31,311,403 +28% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 140,576,297 +31,192,363 +29% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 128,918,552 +32,289,664 +33% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 126,649,205 +33,285,266 +36% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 110,167,984 +21,627,066 +24% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 109,383,934 +25,513,388 +30% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 96,628,888 +13,696,865 +17% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 93,363,939 +10,865,831 +13% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 88,540,918 +11,447,544 +15% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 83,870,546 +10,730,105 +15% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 82,932,023 +12,279,756 +17% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 82,498,108 +14,412,215 +21% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 77,093,374 +10,318,228 +15% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 73,140,441 +16,361,327 +29% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 70,652,267 +15,927,686 +29% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 68,085,893 +13,629,270 +25% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 66,775,146 +12,697,733 +23% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 56,779,114 +2,725,313 +5% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 54,724,581 +2,207,673 +4.2% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 54,456,623 +2,800,068 +5.4% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 54,077,413 +6,646,818 +14% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 54,053,801 +9,120,862 +20% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 52,516,908 +11,077,170 +27% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 51,656,555 +13,535,900 +36% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 47,430,595 +9,946,377 +27% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 44,932,939 +10,638,013 +31% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 41,439,738 +8,039,129 +24% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 38,120,655 +11,398,715 +43% 30 Jun 2014 10-Q 24 Jul 2014 2014 Q2
Q1 2014 37,484,218 +11,161,547 +42% 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 34,294,926 +8,487,714 +33% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 33,400,609 +13,341,614 +67% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 26,721,940 +8,667,945 +48% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 26,322,671 +21,261,272 +420% 31 Mar 2013 10-Q 14 May 2013 2013 Q1
Q4 2012 25,807,212 +20,745,813 +410% 31 Dec 2012 10-K 07 Mar 2014 2013 FY
Q3 2012 20,058,995 +12,660,679 +171% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 18,053,995 +15,458,129 +595% 30 Jun 2012 10-Q/A 07 Sep 2012 2012 Q2
Q1 2012 5,061,399 31 Mar 2012 10-Q 14 May 2012 2012 Q1
Q4 2011 5,061,399 +2,642,094 +109% 31 Dec 2011 10-K 21 Mar 2013 2012 FY
Q3 2011 7,398,316 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 2,595,866 30 Jun 2011 10-Q/A 14 Sep 2011 2011 Q2
Q4 2010 2,419,305 31 Dec 2010 10-Q 14 Nov 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.